SavedAdd your journal

Journals / The European Research Journal / 2019 / Cilt: 5 - Sayı: 6

Unusual uterine metastasis of plasmablastic lenfoma: a case report

Suat KARATAŞ
Tayfur ÇİFT
Veysel ŞAL
Meltem TEKELİOĞLU
Özlem TON
Pages
1020–1023
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Genital involvement also appears to be last but possible site option to find PBL focus in immunocompetent patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Plasmablastic lenfoma (PBL) is a diffuse large B-cell lymphoma (DLBCL)’s variant form that is especially reported in HIV-infected patients.
📊
Key Findings & Data:A 51-year-old multipara (G6P4C2) woman with a chief complaint of irregular vaginal bleeding was presented to our outpatient clinic.
💡
Conclusion & Impact:Genital involvement also appears to be last but possible site option to find PBL focus in immunocompetent patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Plasmablastic lymphoma · uterine mass · surgery

Abstract

Plasmablastic lenfoma (PBL) is a diffuse large B-cell lymphoma (DLBCL)’s variant form that is especially reported in HIV-infected patients. PBL is a rare entity seen most commonly in the setting of immunocompromise. However, this disease may present in extraoral sites in which the genital tract appears to be the less common. Here we present a patient with uterine and fallopian mass diagnosed PBL. A 51-year-old multipara (G6P4C2) woman with a chief complaint of irregular vaginal bleeding was presented to our outpatient clinic. She had a prior history of breast cancer treated by right mastectomy and adjuvant chemotherapy.Transvaginal ultrasonography and magnetic resonance imaging both showed an uterine mass thought to be leiomyoma, which 4×3 cm in size on the anterior wall of uterin corpus. The pathology result of the mass was found to be plasmablastic lymphoma. Genital involvement also appears to be last but possible site option to find PBL focus in immunocompetent patients.

🔖

Cite This Article

KARATAŞ, S., ÇİFT, T., ŞAL, V., TEKELİOĞLU, M., TON, Ö. (2019). Unusual uterine metastasis of plasmablastic lenfoma: a case report. The European Research Journal, Cilt: 5 - Sayı: 6, 1020–1023. https://ajindex.com/articles/361017

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. El Fakih R, Almahayni M, Alsermani M. Plasmablastic lymphoma presenting as exophytic skin lesions. Hematol Oncol Stem Cell Ther 2017;10:164-5
  2. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997:15;89:1413-20
  3. Lee OJ, Kim KW, Lee GK. Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med 2006;35:382-4
  4. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90
  5. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-76
  6. Dittus C, Sarosiek S. A case of HIV-negative plasmablastic lymphoma of the bone marrow with a unique immunophenotype. Clin Case Rep 2017;5:902-4
  7. Han X, Duan M, Hu L, Zhou D, Zhang W. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis. Medicine (Baltimore) 2017;96:e5981
  8. Gong J, Alkan S, Anand S. A case of cutaneous plasmablastic lymphoma in HIV/AIDS with disseminated cryptococcus. Case Rep Oncol Med 2013;2013:862585
  9. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis 2009;15:38-45
  10. Komaranchath AS, Haleshappa RA, Kuntegowdenahalli LC, Kumar RV, Dasappa L, Babu G. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis. Indian J Cancer 2016;53:529-33.